Germana Tognon

4PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2025
Clinical Significance of Soluble L1CAM Serum Levels in Patients with High-Risk Endometrial Cancer.

Antonella Ravaggi, Cosetta Bergamaschi, Laura Zanotti

|Sep 18, 2024
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Antonio González-Martín, María Jesús Rubio, Florian Heitz

|Feb 05, 2024
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.

Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli

Pageof 1